dehydroepiandrosterone sulfate has been researched along with Attention Deficit Disorder with Hyperactivity in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, MC; Chou, WJ; Lee, MJ; Lee, SY; Wang, LJ | 1 |
| Davies, W; Eddy, JB; Humby, T; Ojarikre, OA; Trent, S; Wilkinson, LS | 1 |
| Burgoyne, PS; Davies, W; Humby, T; Kong, W; Otter, T; Wilkinson, LS | 1 |
| Averbuch, E; Maayan, R; Nechmad, A; Spivak, B; Strous, R; Weizman, A; Yoran-Hegesh, R | 1 |
| Han, C; Joe, SH; Jung, IK; Kim, SH; Ko, YH; Lee, MS; Yang, JW | 1 |
| Averbuch, E; Kotler, M; Maayan, R; Mester, R; Spivak, B; Strous, RD; Weizman, A; Yoran-Hegesh, R | 1 |
2 trial(s) available for dehydroepiandrosterone sulfate and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Male; Methylphenidate; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2003 |
Analysis of neurosteroid levels in attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Male; Neurotransmitter Agents; Pregnenolone; Psychiatric Status Rating Scales; Steroids | 2001 |
4 other study(ies) available for dehydroepiandrosterone sulfate and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Dehydroepiandrosterone sulfate, free testosterone, and sex hormone-binding globulin on susceptibility to attention-deficit/hyperactivity disorder.
Topics: Adolescent; Androgens; Attention Deficit Disorder with Hyperactivity; Biomarkers; Child; Dehydroepiandrosterone Sulfate; Disease Susceptibility; Female; Humans; Male; Sex Factors; Sex Hormone-Binding Globulin; Testosterone | 2019 |
Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Central Nervous System Stimulants; Coumarins; Dehydroepiandrosterone Sulfate; Disease Models, Animal; Enzyme Inhibitors; Inhibition, Psychological; Male; Methylphenidate; Mice, Transgenic; Neuropsychological Tests; Propylamines; Psychomotor Performance; Steryl-Sulfatase; Sulfonamides | 2014 |
Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Choice Behavior; Coumarins; Dehydroepiandrosterone Sulfate; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Motor Activity; Reaction Time; Steryl-Sulfatase; Sulfonamides | 2009 |
Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.
Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Biomarkers; Bupropion; Central Nervous System Stimulants; Child; Dehydroepiandrosterone Sulfate; Humans; Hydrocortisone; Korea; Male; Methylphenidate; Treatment Outcome | 2008 |